To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Contact Lenses: Sales
Friday 19th December 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to (1) extend regulatory powers, (2) improve reporting mechanisms, and (3) work with (a) online platforms, (b) manufacturers, (c) professional bodies, and (d) enforcement agencies, to address the illegal online sale of optical appliances.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) establish the statutory framework that medical devices must meet in order to comply with these standards.

Optical appliances as medical devices must comply with the MDR 2002, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers or their UK representatives must also monitor the use of these devices when used in the UK and report serious incidents to the MHRA. Allegations of deficiencies and incidents that do not meet these standards must be reported to the MHRA through the Yellow card scheme or informed though published guidance around enforcement and compliance.


Written Question
Ophthalmic Services: Sales
Friday 19th December 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to strengthen enforcement against the illegal online sale of optical appliances, including by overseas suppliers operating in the UK market.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 establish the statutory framework that medical devices must meet in order to comply with these standards.

Optical appliances as medical devices must comply with requirements set out in the regulatuons, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers based outside of the United Kingdom must have a UK responsible person, and all devices must be registered with the MHRA prior to being placed on the market. Manufacturers or their UK representatives must also monitor use of these devices when used in the UK and report serious incidents to the MHRA.

The MHRA ensure that medical devices placed on the market and put into service in the UK meet these regulatory requirements by: assessing all allegations of non-compliance brought to us, using a risk-based system; monitoring the activity of UK approved bodies we designate to assess the compliance of manufacturers; and investigating medical devices as a result of adverse incident reports or intelligence indicating a potential problem.

If the MHRA considers that a product is breaching the medical devices regulations, typically, the MHRA Devices Compliance Unit will contact the manufacturer or, if the manufacturer is based outside of the UK, the UK Responsible Person, outlining the agency’s concerns and requesting further information with a view to bringing them into compliance.

If a manufacturer fails to co-operate with our requests and continues to place a non-compliant product on the market, or there is a serious risk to public health, the MHRA may consider using our enforcement powers. Guidance on how we enforce medical device regulations is available at the following link:

https://www.gov.uk/government/publications/report-a-non-compliant-medical-device-enforcement-process/how-mhra-ensures-the-safety-and-quality-of-medical-devices

In addition to our investigatory and enforcement activities, the MHRA maintain ongoing relationships with external stakeholders including major online selling platforms to address non-compliant listings of medical devices available on the UK market, including those listed on overseas websites. This collaboration typically involves reporting mechanisms and proactive engagement with external online platforms to identify, address and prevent non-compliant listings.


Written Question
Medical Equipment: Regulation
Friday 19th December 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they plan to update medical device regulations to bring UK-based online contact lens retailers under a clear regulatory framework; and whether they plan to introduce measures including (1) a recognised compliance mark, (2) stronger border controls, and (3) oversight to ensure customers identify lawful suppliers and reduce the risk of eye infections.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) establish the statutory framework that medical devices must meet in order to comply with these standards.

Opthalmic medical devices must comply with the MDR 2002, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers or their UK representatives must also monitor use of these devices when used in the UK. Allegations of deficiencies that do not meet these standards must be reported to the MHRA through the Yellow card scheme or informed though published guidance, with further information available on the GOV.UK website.

The MHRA is not responsible for the movement of medical devices across borders.


Written Question
Directors: Proof of Identity
Wednesday 19th November 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department for Business and Trade:

To ask His Majesty's Government what allowance is made under the Companies House requirement for company directors to verify their identity online, or by starting the process on-line, for those who do not have access to the internet or the ability to apply in this way.

Answered by Baroness Lloyd of Effra - Baroness in Waiting (HM Household) (Whip)

Companies House have invested in expansion and training of our customer service team to assist users in their identity verification journey. This includes establishing a specialist team to support customers who have accessibility requirements.

Users can ask someone they know to help them prove their identity: https://www.gov.uk/guidance/help-someone-use-govuk-one-login. Where identity cannot be verified online, users may be directed to complete the process in person at a participating Post Office. The invitation to initiate this journey can be issued via post.

Authorised Company Service Providers may also offer non-digital identity verification services.


Written Question
Foreign, Commonwealth and Development Office: Dismissal
Monday 20th October 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Foreign, Commonwealth & Development Office:

To ask His Majesty's Government, further to the Written Answer by Baroness Chapman of Darlington on 9 April (HL5959), what progress has been made in identifying and possibly contacting civil servants dismissed from the Foreign, Commonwealth and Development Office as a result of the then-ban on homosexuals serving in the Diplomatic Service.

Answered by Baroness Chapman of Darlington - Minister of State (Development)

The Cabinet Office is continuing to review this matter, given the wider implications beyond former Foreign & Commonwealth Office staff, and they will update Parliament on the outcome in due course.


Written Question
Roads: Repairs and Maintenance
Monday 20th October 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department for Transport:

To ask His Majesty's Government what assessment they have made of potential mandatory training for those local authorities which, according to local road maintenance transparency reports, are not carrying out any preventative road maintenance.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

To qualify for their full share of this year’s £500m uplift in highways maintenance funding, local authorities had to publish transparency reports and set out how they comply with best practice, including in relation to preventative maintenance which is more cost effective than the reactive patching of potholes. The findings from the transparency reports enable the department to identify where extra support may be needed to ensure compliance with best practice. The department will set out more detail on the further support and training it will make available to local authorities in due course.


Written Question
Roads: Repairs and Maintenance
Thursday 16th October 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Department for Transport:

To ask His Majesty's Government what steps they are taking to encourage local authorities to prioritise preventative road maintenance treatments over short-term pothole repairs.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

There are occasions where potholes need to be repaired quickly for safety reasons, but the Department encourages local authorities to focus on long-term preventative maintenance, which is more cost-effective than the reactive patching of potholes. To qualify for their full share of this year's £500m uplift in highways maintenance funding, local authorities had to publish transparency reports and set out how they comply with best practice including in relation to the extent to which they prioritise preventative maintenance.


Written Question
Special Advisers: Lobbying
Wednesday 30th July 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Cabinet Office:

To ask His Majesty's Government whether they plan to include special advisors within the scope of the Transparency of Lobbying, Non-Party Campaigning and Trade Union Administration Act 2014 using the powers in section 2(5) of that Act.

Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)

The Government is committed to transparency and has already taken a number of steps to restore trust in politics. The Government currently has no plans to bring Special Advisers within the scope of the Lobbying Act, although it continues to keep transparency and lobbying under review.


Written Question
Money Laundering and Terrorist Financing (Amendment) Regulations 2023
Tuesday 15th July 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the HM Treasury:

To ask His Majesty's Government what progress they have made in implementing the Money Laundering and Terrorist Financing (Amendment) Regulations 2023, and in updating the Financial Conduct Authority guidance with regard to politically exposed people.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

The Money Laundering and Terrorist Financing (Amendment) Regulations 2023 came into force on 10 January 2024. All businesses within scope of the Money Laundering Regulations are now required to ensure that their starting point for assessing the risk posed by domestic politically exposed persons (PEPs), and the extent of the enhanced customer due diligence measures to be applied in relation to that customer, is that they present a lower level of risk than a non-domestic PEP.

The Government has been working closely with the FCA to follow up on the findings of its review into the treatment of Politically Exposed Persons (PEPs) by financial institutions and to ensure firms improve their practices where necessary. Following a consultation, the FCA published updated guidance on PEPs on 7 July 2025. It is available here: https://www.fca.org.uk/publications/finalised-guidance/fg25-3-treatment-politically-exposed-persons


Written Question
Lobbying
Thursday 3rd July 2025

Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)

Question to the Cabinet Office:

To ask His Majesty's Government whether they plan to respond to the calls for greater control over lobbying made by the Chartered Institute of Public Relations in its report, No Rules Britannia? The UK’s lobbying laws exposed on the global stage, published in April.

Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)

In addition to steps this Government has already taken to improve transparency, in particular through the introduction of the monthly register of ministers' gifts and hospitality, the Government continues to develop its broader work on ethics and standards and will provide an update in due course.